Raia Drogasil SA
BOVESPA:RADL3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Raia Drogasil SA
Cash from Investing Activities
Raia Drogasil SA
Cash from Investing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Raia Drogasil SA
BOVESPA:RADL3
|
Cash from Investing Activities
-R$1.4B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-14%
|
|
|
Empreendimentos Pague Menos SA
BOVESPA:PGMN3
|
Cash from Investing Activities
-R$254.7m
|
CAGR 3-Years
28%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
|
Dimed SA Distribuidora de Medicamentos
BOVESPA:PNVL3
|
Cash from Investing Activities
-R$383.3m
|
CAGR 3-Years
-43%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-28%
|
|
|
d
|
d1000 Varejo Farma Participacoes SA
BOVESPA:DMVF3
|
Cash from Investing Activities
-R$92.4m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
Raia Drogasil SA
Glance View
Raia Drogasil SA, Brazil's pharmaceutical titan, stands as a testament to the transformative power of strategic mergers and innovative retail management. Born out of the merger of Drogasil and Droga Raia, two of Brazil's enduring pharmacy chains, the company today operates an extensive network of retail stores across the nation. This strategic merger in 2011 was not merely a consolidation of operations but a fusion of distinct corporate cultures and expertise, aimed at enhancing operational efficiencies and expanding market share. By leveraging economies of scale, Raia Drogasil has entrenched itself as a formidable force in Brazil's healthcare retail sector, boasting a strong presence in both high-density urban centers and emerging markets in Brazil. The company's business model is built on a robust mix of health and wellness products, encompassing everything from prescription medications to over-the-counter remedies and personal care items. Raia Drogasil has adeptly positioned itself to capitalize on Brazil's growing healthcare demands, thanks to its comprehensive product offerings and strategic store locations. Each store functions as both a destination for health-conscious consumers and a vital link in the greater logistical chain that ensures timely product availability. By intertwining brick-and-mortar retail with digital innovation, Raia Drogasil not only drives revenue through traditional sales channels but also through its dynamic e-commerce platform. This synergy allows the company to tap into the evolving preferences of tech-savvy consumers, thereby making Raia Drogasil a leader in seamlessly integrating shopping experiences that cater to modern customer expectations.
See Also
What is Raia Drogasil SA's Cash from Investing Activities?
Cash from Investing Activities
-1.4B
BRL
Based on the financial report for Dec 31, 2025, Raia Drogasil SA's Cash from Investing Activities amounts to -1.4B BRL.
What is Raia Drogasil SA's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-14%
Over the last year, the Cash from Investing Activities growth was 1%. The average annual Cash from Investing Activities growth rates for Raia Drogasil SA have been -5% over the past three years , -16% over the past five years , and -14% over the past ten years .